TIP832: Fairfax Financial (FFO.TO): The Berkshire Of The North w/ Kyle Grieve & Shawn O'Malley
Episode
66 min
Read time
3 min
Topics
Career Growth, Investing, Fundraising & VC
AI-Generated Summary
Key Takeaways
- ✓Float as free leverage: Fairfax grew its insurance float from $13M in 1985 to $40.8B today by acquiring underperforming insurers and deploying float capital at 7.7% long-term returns versus the industry average of ~4%. When combined with a sub-100% combined ratio (averaging ~97% since 2006), the company effectively gets paid to hold and invest other people's money — a structural advantage most insurers never achieve simultaneously.
- ✓Post-GFC hedging mistake: Fairfax netted $4.6B from CDS bets during the 2008 crisis — four times Michael Burry's gain — but then spent 2010–2016 shorting the S&P 500 and Russell 2000, wiping out nearly all operating income and limiting book value growth to 2% annually. Watsa publicly admitted the error and permanently abandoned shorting. Investors should recognize that crisis-era scars systematically distort future risk assessments, even for elite capital allocators.
- ✓Tactical buyback execution: During COVID-19, Fairfax purchased total return swaps on its own stock after shares dropped ~50%, ultimately generating ~$2B in cash proceeds used for further share repurchases. Share count declined from 28M to 23M since 2018, with buybacks executed at prices as low as $473–$500 versus today's ~$2,340. Timing buybacks at maximum pessimism, not all-time highs, is the key differentiator between value-destructive and value-creative capital return programs.
- ✓Non-dilutive options structure: Fairfax grants equity awards using shares already purchased on the open market rather than newly issued shares, making compensation entirely non-dilutive — a structure described as exceptionally rare. Vesting runs 50% at five years and 50% at ten years, with expiration dates extending past 2040. This forces boards to treat compensation as a real cash expense, naturally constraining package sizes and aligning executive time horizons with long-term shareholder value creation.
- ✓Insurance valuation framework: Evaluate insurance holding companies using return on equity rather than ROIC, then apply a price-to-book multiple to terminal book value. At Fairfax's stated 15% ROE target (below its five-year average of ~21%), applying a 1.3x book multiple produces a 2030 terminal value of ~CAD $4,600 including dividends, implying ~14.7% annualized returns. Bear case at 11% ROE with 1.0x book still yields ~5.3% annually, demonstrating meaningful downside protection.
What It Covers
Kyle Grieve and Shawn O'Malley analyze Fairfax Financial (FFH.TO), a Canadian insurance holding company led by Prem Watsa that has compounded book value at 18% annually since 1985. The episode covers Fairfax's business model, GFC bet, capital allocation strategies, competitive advantages, management structure, valuation, and comparison to Berkshire Hathaway.
Key Questions Answered
- •Float as free leverage: Fairfax grew its insurance float from $13M in 1985 to $40.8B today by acquiring underperforming insurers and deploying float capital at 7.7% long-term returns versus the industry average of ~4%. When combined with a sub-100% combined ratio (averaging ~97% since 2006), the company effectively gets paid to hold and invest other people's money — a structural advantage most insurers never achieve simultaneously.
- •Post-GFC hedging mistake: Fairfax netted $4.6B from CDS bets during the 2008 crisis — four times Michael Burry's gain — but then spent 2010–2016 shorting the S&P 500 and Russell 2000, wiping out nearly all operating income and limiting book value growth to 2% annually. Watsa publicly admitted the error and permanently abandoned shorting. Investors should recognize that crisis-era scars systematically distort future risk assessments, even for elite capital allocators.
- •Tactical buyback execution: During COVID-19, Fairfax purchased total return swaps on its own stock after shares dropped ~50%, ultimately generating ~$2B in cash proceeds used for further share repurchases. Share count declined from 28M to 23M since 2018, with buybacks executed at prices as low as $473–$500 versus today's ~$2,340. Timing buybacks at maximum pessimism, not all-time highs, is the key differentiator between value-destructive and value-creative capital return programs.
- •Non-dilutive options structure: Fairfax grants equity awards using shares already purchased on the open market rather than newly issued shares, making compensation entirely non-dilutive — a structure described as exceptionally rare. Vesting runs 50% at five years and 50% at ten years, with expiration dates extending past 2040. This forces boards to treat compensation as a real cash expense, naturally constraining package sizes and aligning executive time horizons with long-term shareholder value creation.
- •Insurance valuation framework: Evaluate insurance holding companies using return on equity rather than ROIC, then apply a price-to-book multiple to terminal book value. At Fairfax's stated 15% ROE target (below its five-year average of ~21%), applying a 1.3x book multiple produces a 2030 terminal value of ~CAD $4,600 including dividends, implying ~14.7% annualized returns. Bear case at 11% ROE with 1.0x book still yields ~5.3% annually, demonstrating meaningful downside protection.
- •Decentralization as retention tool: Fairfax maintains presidents at subsidiary insurance companies for multiple decades by acquiring well-run businesses and leaving management structures intact. Internal promotion is the default, not the exception. This matters in insurance specifically because underwriting quality only reveals itself across multiple cycles — firing managers mid-cycle before reserve deficiencies or redundancies surface destroys institutional knowledge and resets the underwriting improvement timeline by years.
Notable Moment
Fairfax sold a 10% stake in its Odyssey reinsurance subsidiary at 1.7x book value — a premium multiple — then used those proceeds to repurchase Fairfax shares trading at just 0.9x book. The maneuver simultaneously monetized an overvalued asset and bought an undervalued one, concentrating shareholder ownership without issuing new capital.
Episode Transcript
You're listening to TIP. The fact that they compound at at 18% a year for over forty years now, that's just unbelievable. I mean, it has to be one of the most under the radar long term success stories that we've ever come across. Trey Lockerbie (zero fifty three:thirty seven): Right? To think it all started with acquiring a nearly bankrupt Canadian trucking insurance business with just $13,000,000 in float and has now grown that to nearly $41,000,000,000 Matt Spielman (zero fifty three:forty nine): The bet they put on the housing bubble during the GFC was like absolutely incredible trade. Right? And I think they netted over $4,500,000,000. And so really the big short should have been about them, not Michael Burry. Since 2014, with more than 200,000,000 downloads, we have interviewed the world's best investors, studied deeply the principles of value investing, and uncovered many compelling investment opportunities. We focus on understanding businesses and intrinsic value, investing accordingly, and sharing everything we learn with you. This show is not investment advice. It's intended for informational and entertainment purposes only. All opinions expressed by hosts and guests are solely their own, and they may have investments in the securities discussed. Now for your hosts, Sean O'Malley and Kyle Grieve. This episode is brought to you by Accenture. When your advertising operations fall out of sync, everything else follows. Spotify and Accenture are working together to reinvent the rhythm of ad sales using automation, analytics, and smarter workflows to to simplify campaign delivery and access better data across the business. The result, less time spent on operations, more time connecting brands with the moments and fandoms that matter most. Learn more at accenture.com/spotify. Daniel and I researched the gold standard of value investments when we looked at Berkshire Hathaway last year, and fittingly, we added it as a position to the intrinsic value portfolio that we run. So, we have some experience looking at insurance based holding companies, and Berkshire Hathaway is one of the best simply because they have the world's best capital allocator leading the business, and Warren Buffett, and he led it for many, many decades, but I'm excited to look at another insurance business that tends to run much more under the radar than Berkshire simply because its CEO, Prem Watsa, doesn't quite have the same cult like following as Buffett and lives in Canada too, not The US, so maybe that's a factor. For a lot of diehard investors though, going to this company's annual shareholder meeting is just as important as going to Berkshire's. Jason Brett (zero zero three:thirty one): That's right. This business is Fairfax Financial and it's compounded its book value at over 18% per year since 1985. Now interestingly, one of the biggest tenants in value investing is that price follows intrinsic value over the long term. And Fairfax has done just that, compounding its share price at 18% as well. And since 1986, when Fairfax had positive earnings per share, it …
Get the full transcript (13,403 words) + summary by email — free
One-time email with the complete transcript and AI summary of this episode. No account needed.
One email, no spam. We’ll also show you what SignalCast does.
You just read a 3-minute summary of a 63-minute episode.
Get We Study Billionaires summarized like this every Monday — plus up to 2 more podcasts, free.
Pick Your Podcasts — FreeKeep Reading
More from We Study Billionaires
TIP843: AppLovin (APP): The 30-Bagger Down More Than Half w/ Kyle Grieve & Shawn O'Malley
Sep 3 · 90 min
This Week in Startups
Why SpaceX Buying Cursor Changes Everything
Jun 18
More from We Study Billionaires
TIP842: Comfort Systems USA (FIX): The Five-Bagger We Passed On w/ Kyle Grieve & Shawn O'Malley
Aug 30 · 79 min
The Daily (NYT)
A Gen Z Revolution at the Movies
Jun 16
More from We Study Billionaires
We summarize every new episode. Want them in your inbox?
TIP843: AppLovin (APP): The 30-Bagger Down More Than Half w/ Kyle Grieve & Shawn O'Malley
TIP842: Comfort Systems USA (FIX): The Five-Bagger We Passed On w/ Kyle Grieve & Shawn O'Malley
TIP841: Palantir – Palantir is Cheaper than I Thought! w/ Daniel Mahncke & Shawn O’Malley
TIP840: CATL: Powering EVs, Power Grids, and AI w/ Stig Brodersen, Manish Karira & Ralph Summerford
TIP839: Domino's Pizza (DPZ): Is the Royalty Engine Still Running? w/ Kyle Grieve & Shawn O’Malley
Similar Episodes
Related episodes from other podcasts
This Week in Startups
Jun 18
Why SpaceX Buying Cursor Changes Everything
The Daily (NYT)
Jun 16
A Gen Z Revolution at the Movies
The Knowledge Project
Jun 9
Mental Models That Change How You Think | Bill Gurley
Investing for Beginners
May 21
Birdseye View: Caterpillar (CAT) — Moat, Dealers, and the “Picks & Shovels” of the AI Boom
Odd Lots
Apr 16
Brad Setser on the War in Iran and the Future of the US Dollar
Explore Related Topics
This podcast is featured in Best Investing Podcasts (2026) — ranked and reviewed with AI summaries.
Read this week's Investing & Markets Podcast Insights — cross-podcast analysis updated weekly.
You're clearly into We Study Billionaires.
Every Monday, we deliver AI summaries of the latest episodes from We Study Billionaires and 192+ other podcasts. Free for one show.
Start My Monday DigestNo credit card · Unsubscribe anytime